Proposed Data Collection Submitted for Public Comment and Recommendations, 53374-53376 [2020-19010]
Download as PDF
<![CDATA[
53374
Federal Register / Vol. 85, No. 168 / Friday, August 28, 2020 / Notices
GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–00XX; Docket No.
2020–0001; Sequence No. 2]
Information Collection; Technology
Transformation Services—Candidate
Experience Surveys
Technology Transformation
Services (TTS), Federal Acquisition
Service (FAS), General Services
Administration (GSA).
ACTION: Notice.
AGENCY:
Under the provisions of the
Paperwork Reduction Act, the
Regulatory Secretariat Division will be
submitting to the Office of Management
and Budget (OMB) a request to review
and approve a new information
collection requirement regarding
sending candidate surveys to all
applicants who apply to jobs within the
Technology Transformation Services
(TTS).
DATES: Submit comments on or before
September 28, 2020.
ADDRESSES: Written comments and
recommendations for this information
collection should be sent within 30 days
of publication of this notice to
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. If your
comment cannot be submitted using
www.reginfo.gov/public/do/PRAMain,
call or email the points of contact in the
SUMMARY:
FOR FURTHER INFORMATION CONTACT
section of this document for alternate
instructions.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to Jennifer Moran,
Technology Transformation Services at
202–501–4755 or via email to
jennifer.moran@gsa.gov.
SUPPLEMENTARY INFORMATION:
A. Purpose
The goal of TTS is to modernize the
way the government uses technology by
applying modern methodologies and
technologies to improve the public’s
experience with government. In order to
accomplish this, we need to be able to
attract top technical talent from across
the country. This often means
competing for talent with the private
sector, where companies can often offer
more robust compensation and benefits.
In order to remain competitive, it is
vital that we provide an exceptional
candidate experience and maintain a
strong brand reputation. Some of the
ways we strive to do this is through
VerDate Sep<11>2014
17:16 Aug 27, 2020
Jkt 250001
providing clear job descriptions,
thorough interview preparation and
personalized candidate experience
throughout the process. In doing so, we
are better able to recruit more
candidates into doing a tour of duty in
the government. Candidate Surveys are
a way for us to continuously measure
how we are doing and make any
necessary improvements to our hiring
process so we can continue to hire and
attract the top talent we need at the rate
we need them in this demanding
market.
By consistently asking applicants and
candidates for their feedback and
reviewing the survey results, we can
pinpoint what areas in our process need
to be modified, changed, removed, and/
or added. Surveys allow respondents to
remain anonymous and will be sent out
three times during the hiring process:
• After a candidate applies to a role.
Data at this stage will help us
understand if our job descriptions
provide a clear understanding of the
roles and responsibilities that we are
hiring for. It will also help us
understand if our website has thorough
enough information about the overall
hiring process or if there are more
resources that we can be providing.
• After a candidate interviews. Data
at this stage will help us understand if
we are properly preparing candidates
and interviewers for interviews.
• When the candidate is Selected or
Not Selected after the Interview. Data at
this stage will help us understand what
the candidate’s experience was with
their TTS recruiter overall and if there
is anything they think we can improve
upon.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–20ML; Docket No. CDC–2020–
0096]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
C. Public Comments
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Cruise Operator COVID–19
Response Plans,’’ which will provide
CDC with the ability require cruise ship
operators to submit plans outlining their
response procedures for preventing the
spread of COVID–19 onboard, and for
preventing the use of scarce U.S.
domestic resources in response to
COVID–19 cases originating on cruise
ships.
DATES: CDC must receive written
comments on or before October 27,
2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2019–
0096 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
A notice published in the Federal
Register at 85 FR 32394 on May 29,
2020. No comments were received.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
B. Annual Reporting Burden
Respondents: 7,400.
Responses per Respondent: 1–3.
Total Annual Responses: 1,110.
Hours per Response: 5 minutes per
survey.
Total Burden Hours: 15 minutes for
candidates who complete all 3 surveys.
[FR Doc. 2020–18959 Filed 8–27–20; 8:45 am]
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger, of
the Information Collection Review
FOR FURTHER INFORMATION CONTACT:
Beth Anne Killoran,
Deputy Chief Information Officer.
BILLING CODE 6820–34–P
SUMMARY:
E:\FR\FM\28AUN1.SGM
28AUN1
53375
Federal Register / Vol. 85, No. 168 / Friday, August 28, 2020 / Notices
Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
disembarkation of passengers or crew is
conducted in such a way as to not result
in further spread of COVID–19. An
appropriate plan shall not significantly
burden U.S. government operations or
the operations of any state or local
government, including the U.S.
healthcare system. The cruise ship
operator shall further ensure that the
plan is consistent with CDC
recommendations and guidance for any
public health actions related to COVID–
19. As a condition of the granting of
controlled free pratique to continue to
engage in any cruise ship operations in
any international, interstate, or
intrastate waterways subject to the
jurisdiction of the United States, the
cruise ship operator shall present the
plan, upon request, to U.S. Coast Guard
and HHS/CDC personnel.
Within these plans are notification
requirements that obligate cruise ship
operators to provide CDC and local
health departments in the follow
circumstances:
Proposed Project
Cruise Operator COVID–19 Response
Plans—New—National Center for
Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC)
Background and Brief Description
Recent CDC actions in response to
COVID onboard maritime vessels has
shown that cruise ship travel markedly
increases the risk and impact of the
COVID–19 disease outbreak within the
United States. If unrestricted cruise ship
passenger operations are permitted to
resume after the March 14, 2020 No Sail
Order, infected and exposed cruise ship
cases would place healthcare workers at
substantial increased risk. Specifically,
these cases would divert medical
resources away from persons with other
medical problems and other COVID–19
cases, consuming precious diagnostics,
therapeutics, and protective equipment.
Ongoing concerns with cruise ship
transmission would further draw
valuable resources away from the
immense Federal, state, and local effort
to contain and mitigate the spread of
COVID–19. Further, the current ongoing
non-passenger operation of cruise ships
has not sufficiently abated the public
health concern, as ship crews become
sick and require medical care drawing
on otherwise engaged Federal, state, and
local resources. As operators of non-U.S.
flagged vessels sailing in international
waters, it is imperative that the cruise
ship industry and cruise lines
themselves take responsibility for the
care of their crew and do not further tax
limited U.S. resources during a public
health emergency.
CDC is therefore implementing a
requirement within an extended No Sail
Order that obligates cruise operators to
develop and implement a plan that
adequately prevents, mitigates, and
responds to the spread of COVID–19 on
board cruise ships and ensures that any
• Disembarking U.S. residents who plan
to leave the ships and travel by
private transport
• Disembarking crew to the United
States for repatriation via noncommercial travel to home countries
• Crew transfers for purposes such as
maintaining Minimum Safe Manning
standards
In addition, cruise ship operators can
choose to submit an attestation
statement to CDC attesting that their
ship is free of COVID–19. If this is
statement is accepted, cruise ship
operators have the option to repatriate
their crew via commercial travel.
There are no costs to respondents
other than their time to develop and
submit the plan and the required
notifications to CDC, U.S. Coast Guard,
and the local or state health authority,
as directed.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondent
Form
Cruise ship operator .........................
COVID–19 Response Plan (no
form).
72-hour notification to CDC of disembarkation or U.S. residents for
private travel.
72-hour notification to state/local
health department of disembarkation for crew repatriation.
72-hour notification for crew transfers.
Cruise ship operator .........................
Cruise ship operator .........................
Cruise ship operator .........................
VerDate Sep<11>2014
17:16 Aug 27, 2020
Jkt 250001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in minutes)
Total burden
hours
100
1
2,400/60
4,000
100
5
5/60
42
100
2
5/60
17
100
5
5/60
42
E:\FR\FM\28AUN1.SGM
28AUN1
53376
Federal Register / Vol. 85, No. 168 / Friday, August 28, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in minutes)
Total burden
hours
Respondent
Form
Cruise ship operator .........................
Attestation statement of COVID–19
free ship (for repatriating crew via
commercial travel).
100
1
20/60
33
Total ...........................................
...........................................................
........................
........................
........................
4,134
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–19010 Filed 8–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
Centers for Disease Control and
Prevention
[60Day–20–1218; Docket No. CDC–2020–
0091]
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Evaluation of MedicationAssisted Treatment (MAT) for Opioid
use disorder.’’ CDC will use the
collection to continue the epidemiologic
study to assess the type of MAT
(methadone maintenance;
buprenorphine; naltrexone; or,
counseling, no MAT), and the
contextual, provider, and individual
factors that influence implementation
and improved patient wellbeing.
DATES: Written comments must be
received on or before October 27, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0091 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
VerDate Sep<11>2014
17:16 Aug 27, 2020
Jkt 250001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
FOR FURTHER INFORMATION CONTACT:
Proposed Data Collection Submitted
for Public Comment and
Recommendations
SUMMARY:
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Evaluation of Medication-Assisted
Treatment (MAT) for Opioid Use
Disorder—Revision—National Center
for Injury Prevention and Control
(NCIPC), Centers for Disease Control
and Prevention (CDC)
Background and Brief Description
CDC seeks a one-year OMB approval
to continue collecting data for
Medication-Assisted Treatment (MAT)
for Opioid use disorder. Approximately
2.4 million people aged 18 or older have
opioid use disorders (OUDs) in the
United States. At any given time, only
half of these people receive some form
of treatment, which may include
medication-assisted treatment (MAT) or
abstinence-based psychotherapy or selfhelp treatments (i.e., counseling without
medication [COUN]). The rise in opioid
overdose deaths, up from 2014–2015
due partly to a 72% rise in synthetic
opioid overdose deaths alone, shows
that engaging and retaining clients in
OUD treatment is an urgent public
health need. Only a few studies are
available to help clients and providers
make informed decisions about the risks
and benefits associated with the
different types of MATs. This
information is crucial because even
though each MAT drug helps prevent
withdrawal symptoms and decreases
cravings, differences in treatment
approach and settings influence how
people respond to the medication and,
thus, their long-term treatment success.
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 85, Number 168 (Friday, August 28, 2020)]
[Notices]
[Pages 53374-53376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19010]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-20ML; Docket No. CDC-2020-0096]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Cruise Operator COVID-19
Response Plans,'' which will provide CDC with the ability require
cruise ship operators to submit plans outlining their response
procedures for preventing the spread of COVID-19 onboard, and for
preventing the use of scarce U.S. domestic resources in response to
COVID-19 cases originating on cruise ships.
DATES: CDC must receive written comments on or before October 27, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0096 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, of the Information
Collection Review
[[Page 53375]]
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Cruise Operator COVID-19 Response Plans--New--National Center for
Emerging Zoonotic and Infectious Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC)
Background and Brief Description
Recent CDC actions in response to COVID onboard maritime vessels
has shown that cruise ship travel markedly increases the risk and
impact of the COVID-19 disease outbreak within the United States. If
unrestricted cruise ship passenger operations are permitted to resume
after the March 14, 2020 No Sail Order, infected and exposed cruise
ship cases would place healthcare workers at substantial increased
risk. Specifically, these cases would divert medical resources away
from persons with other medical problems and other COVID-19 cases,
consuming precious diagnostics, therapeutics, and protective equipment.
Ongoing concerns with cruise ship transmission would further draw
valuable resources away from the immense Federal, state, and local
effort to contain and mitigate the spread of COVID-19. Further, the
current ongoing non-passenger operation of cruise ships has not
sufficiently abated the public health concern, as ship crews become
sick and require medical care drawing on otherwise engaged Federal,
state, and local resources. As operators of non-U.S. flagged vessels
sailing in international waters, it is imperative that the cruise ship
industry and cruise lines themselves take responsibility for the care
of their crew and do not further tax limited U.S. resources during a
public health emergency.
CDC is therefore implementing a requirement within an extended No
Sail Order that obligates cruise operators to develop and implement a
plan that adequately prevents, mitigates, and responds to the spread of
COVID-19 on board cruise ships and ensures that any disembarkation of
passengers or crew is conducted in such a way as to not result in
further spread of COVID-19. An appropriate plan shall not significantly
burden U.S. government operations or the operations of any state or
local government, including the U.S. healthcare system. The cruise ship
operator shall further ensure that the plan is consistent with CDC
recommendations and guidance for any public health actions related to
COVID-19. As a condition of the granting of controlled free pratique to
continue to engage in any cruise ship operations in any international,
interstate, or intrastate waterways subject to the jurisdiction of the
United States, the cruise ship operator shall present the plan, upon
request, to U.S. Coast Guard and HHS/CDC personnel.
Within these plans are notification requirements that obligate
cruise ship operators to provide CDC and local health departments in
the follow circumstances:
Disembarking U.S. residents who plan to leave the ships and
travel by private transport
Disembarking crew to the United States for repatriation via
non-commercial travel to home countries
Crew transfers for purposes such as maintaining Minimum Safe
Manning standards
In addition, cruise ship operators can choose to submit an
attestation statement to CDC attesting that their ship is free of
COVID-19. If this is statement is accepted, cruise ship operators have
the option to repatriate their crew via commercial travel.
There are no costs to respondents other than their time to develop
and submit the plan and the required notifications to CDC, U.S. Coast
Guard, and the local or state health authority, as directed.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondent Form Number of responses per per response Total burden
respondents respondent (in minutes) hours
----------------------------------------------------------------------------------------------------------------
Cruise ship operator.......... COVID-19 100 1 2,400/60 4,000
Response Plan
(no form).
Cruise ship operator.......... 72-hour 100 5 5/60 42
notification to
CDC of
disembarkation
or U.S.
residents for
private travel.
Cruise ship operator.......... 72-hour 100 2 5/60 17
notification to
state/local
health
department of
disembarkation
for crew
repatriation.
Cruise ship operator.......... 72-hour 100 5 5/60 42
notification
for crew
transfers.
[[Page 53376]]
Cruise ship operator.......... Attestation 100 1 20/60 33
statement of
COVID-19 free
ship (for
repatriating
crew via
commercial
travel).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 4,134
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-19010 Filed 8-27-20; 8:45 am]
BILLING CODE 4163-18-P
